These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6819447)

  • 1. Prevention of secondary cases of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Dec; 31(50):672-4, 679-80. PubMed ID: 6819447
    [No Abstract]   [Full Text] [Related]  

  • 2. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 3. Leads from the MMWR. Update: prevention of Haemophilus influenzae type b disease.
    JAMA; 1986 Apr; 255(15):1990-2. PubMed ID: 3485727
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of contacts of children in day care with invasive Haemophilus influenzae type b disease.
    Dashefsky B; Wald E; Li K
    Pediatrics; 1986 Nov; 78(5):939-41. PubMed ID: 3489921
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary rates of Haemophilus influenzae type b disease among day care contacts.
    Marks MI; Dorchester WL
    J Pediatr; 1987 Aug; 111(2):305-6. PubMed ID: 3497253
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylaxis of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Hightower AW; Broome CV
    JAMA; 1984 Dec; 252(23):3249-50. PubMed ID: 6334756
    [No Abstract]   [Full Text] [Related]  

  • 7. New Haemophilus influenzae type b control strategy: premature commitment to prophylaxis?
    Mann JM; Hull HF
    Pediatrics; 1983 Jul; 72(1):118-21. PubMed ID: 6306544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Ajello G
    JAMA; 1984 May; 251(18):2381-6. PubMed ID: 6368889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More on rifampin prophylaxis against Haemophilus influenzae b in day-care facilities.
    Broome CV; Mortimer EA; Katz SL; Fleming DW; Hightower AW
    N Engl J Med; 1988 Jan; 318(1):48-9. PubMed ID: 3257291
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for dealing with the guidelines: rifampin prophylaxis for day care contacts of patients with serious Haemophilus influenzae type b infections.
    Daum RS; Gilsdorf J; Granoff D; Murphy T; Osterholm M
    J Pediatr; 1984 Nov; 105(5):761-3. PubMed ID: 6334148
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
    Fleming DW; Leibenhaut MH; Albanes D; Cochi SL; Hightower AW; Makintubee S; Helgerson SD; Broome CV
    JAMA; 1985 Jul; 254(4):509-14. PubMed ID: 3874293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations.
    Granoff DM; Daum RS
    J Pediatr; 1980 Nov; 97(5):854-60. PubMed ID: 7000999
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin.
    Granoff DM; Gilsdorf J; Gessert C; Basden M
    Pediatrics; 1979 Mar; 63(3):397-401. PubMed ID: 312483
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of chemoprophylaxis to prevent the spread of Hemophilus influenzae B in day-care facilities.
    Broome CV; Mortimer EA; Katz SL; Fleming DW; Hightower AW
    N Engl J Med; 1987 May; 316(19):1226-8. PubMed ID: 3494944
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease.
    Gessert C; Granoff DM; Gilsdorf J
    Pediatrics; 1980 Jul; 66(1):1-4. PubMed ID: 6967580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b.
    Shapiro ED; Wald ER
    Pediatrics; 1980 Jul; 66(1):5-8. PubMed ID: 6967587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease.
    Murphy TV; Clements JF; Breedlove JA; Hansen EJ; Seibert GB
    N Engl J Med; 1987 Jan; 316(1):5-10. PubMed ID: 3491319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae type b colonization in household contacts of infected and colonized children enrolled in day care.
    Li KI; Dashefsky B; Wald ER
    Pediatrics; 1986 Jul; 78(1):15-20. PubMed ID: 3487771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae type b disease after rifampin prophylaxis in a day care center: possible reasons for its failure.
    Murphy TV; McCracken GH; Moore BS; Gulig PA; Hansen EJ
    Pediatr Infect Dis; 1983; 2(3):193-8. PubMed ID: 6602974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.